UNSPSC 51283801: Dalfopristin

This classification denotes an antibiotic with the molecular formula C34H50N4O9S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R9M4FJE48E, chemically known as virginiamycin m1, 26-((2-(diethylamino)ethyl)sulfonyl)-26,27-dihydro-, (26r,27s)- but generally known as dalfopristin, which bears US NIH Compound Identifier 6323289. European Medicines Agency schedules Dalfopristin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06892MIG.

UNSPSC 51283801 Dalfopristin, a Commodity code, nominally denotes a specific antibiotic active pharmaceutical ingredient, but recent state and local procurement activity under this code shows minimal alignment with that narrow scope. State and local governments issue solicitations tagged to this code seeking broader pharmaceutical and medical supply categories — generic multi-source drugs, over-the-counter products, naloxone, and emergency medical consumables — suggesting either upstream tagging mismatches or the code's use as a catch-all placeholder within some jurisdictions' taxonomies. The issuing bodies span state health and human services agencies, county health departments, cities, and cooperative purchasing alliances. Scope of work includes annual procurement of specific pharmaceutical products through established wholesalers, direct-to-manufacturer prescription programs, medical and first aid supplies for emergency response, and bulk pharmaceutical inventory management across multiple delivery sites and user departments.

Activity concentrates in Florida, Texas, and Minnesota, with recent solicitations posted between January and July 2026. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, posted an RFP on January 20, 2026 (due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed through AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co., with contract term effective July 1, 2026. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026 (due July 26, 2023 — a date anomaly in the source) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually for quarterly delivery to the Seminole County Community Health Building in Sanford, Florida. The City of Tampa's Purchasing Department posted ITB 26-P-00145 on March 25, 2026 (due March 13, 2026) for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, estimated at $700,000.00, with a 5% bid discount reserved for certified Small Local Business Enterprises. The Texas Health and Human Services Commission issued an RFI on April 3, 2026 to gather vendor capabilities regarding direct-to-manufacturer prescription programs outside traditional PBM and GPO relationships, signaling early-stage exploration rather than near-term award.